Modulating cell-to-cell variability and sensitivity to death ligands by co-drugging.
Ontology highlight
ABSTRACT: TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) holds promise as an anti-cancer therapeutic but efficiently induces apoptosis in only a subset of tumor cell lines. Moreover, even in clonal populations of responsive lines, only a fraction of cells dies in response to TRAIL and individual cells exhibit cell-to-cell variability in the timing of cell death. Fractional killing in these cell populations appears to arise not from genetic differences among cells but rather from differences in gene expression states, fluctuations in protein levels and the extent to which TRAIL-induced death or survival pathways become activated. In this study, we ask how cell-to-cell variability manifests in cell types with different sensitivities to TRAIL, as well as how it changes when cells are e
SUBMITTER: Flusberg DA
PROVIDER: S-EPMC3775495 | biostudies-literature | 2013 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA